Company Overview
Snapshot
Founded in January 2004, FluenTech operates with 1–10 employees. The company focuses on developing rehabilitative and assistive technologies for speech impediments, holding a patent for its fluency-shaping software.
Business overview
FluenTech develops and commercializes rehabilitative and assistive technologies designed for individuals with speech impediments. Its core product, Dr. Fluency, is a PC-based therapy solution that incorporates patented fluency-shaping software and a comprehensive online home-based patient training service. This solution enables users to practice daily to maintain speech volubility and fluency, serving the digital healthcare and digital therapeutics markets.
Log in to access full profile ›Company Intelligence Q&A
- What is FluenTech's primary focus?
- FluenTech's primary focus is on developing and commercializing rehabilitative and assistive technologies for individuals with speech impediments.
- What is the main product offered by FluenTech?
- FluenTech's main product is Dr. Fluency, a PC-based therapy solution specifically designed for people who stutter.
- What technology does Dr. Fluency utilize?
- Dr. Fluency incorporates patented fluency-shaping software to assist users in maintaining speech volubility and fluency.
- What kind of service does FluenTech provide alongside its software?
- FluenTech provides a comprehensive online home-based patient training service, allowing users to practice regularly to preserve speech fluency.
- In which sector does FluenTech primarily operate?
- FluenTech operates primarily in the Health Tech & Life Sciences sector, specifically within digital healthcare and digital therapeutics.